# Laure Gossec

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laure-gossec/

## Facts

| Field | Value |
| --- | --- |
| Citations | 45,822 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 95 |
| i10-index | 399 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5091895459 |
| ORCID iD | https://orcid.org/0000-0002-4528-310X |
| Works | 1,141 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [\nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.](https://scholariq.org/papers/neular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/characteristics-associated-with-hospitalisation-for-covid-19-in-people-with/)
- [European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update](https://scholariq.org/papers/european-league-against-rheumatism-eular-recommendations-for-the-management-of/)
- [Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry](https://scholariq.org/papers/factors-associated-with-covid-19-related-death-in-people-with-rheumatic-diseases/)
- [Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry](https://scholariq.org/papers/associations-of-baseline-use-of-biologic-or-targeted-synthetic-dmards-with-covid/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Fibromyalgia and Chronic Fatigue Syndrome Research](https://scholariq.org/topics/fibromyalgia-and-chronic-fatigue-syndrome-research/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.